| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $57.0M | — | — |
| Cost of Revenue | $3.1M | — | — |
| R&D Expense | $12.4M | — | -12.4% |
| SG&A Expense | $48.8M | — | +37.3% |
| Operating Income | -$23.4M | — | +52.8% |
| Interest Expense | $1.3M | — | — |
| Pre-tax Income | -$23.5M | — | +50.6% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$23.5M | — | +54.7% |
| EPS (Basic) | -$0.43 | — | +56.1% |
| EPS (Diluted) | -$0.43 | — | +56.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $213.8M | -6.8% | — |
| Accounts Receivable | $9.9M | +281.7% | — |
| Inventory | $4.0M | +16.7% | — |
| Current Assets | $314.2M | -1.9% | — |
| Total Assets | $328.9M | -1.9% | — |
| Current Liabilities | $60.8M | +6.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$14.5M | — | +69.6% |
| Capital Expenditures | $121K | — | -58.0% |
| Investing Cash Flow | -$901K | — | +75.8% |
| Financing Cash Flow | $1.5M | — | -34.1% |
| Free Cash Flow | -$14.6M | — | +69.5% |
| Long-term Debt | $172.2M | +0.0% | — |
| Total Liabilities | $348.6M | +3.1% | — |
| Stockholders' Equity | -$19.7M | -624.9% | -116.8% |